Long-term results and determinants of mortality after surgery for native and prosthetic valve endocarditis

Background and aim of the study: The study aim was to describe the long-term results and determinants of mortality after operative treatment of native and prosthetic valve endocarditis at a single institution. Methods: Between March 1985 and October 1999,171 patients underwent surgery for native (NVE) or prosthetic valve endocarditis (PVE). NVE was present in 98 patients (57%), and PVE in 73 patients (43%). Mean follow up was 5.6 +/- 3.9 years (range: 0 to 15 years). Results: Overall hospital mortality was 9.9% (n = 17). Hospital mortality was higher among patients with PVE (15.1%) than those with NVE (6.1%; p = 0.05). Overall survival at 10 years was 46 +/- 5%. Patients with NVE had a higher 10-year survival rate (53 +/- 7%) than those with PVE (37 +/- 7%; p = 0.02). At 10 years, overall freedom from any late complication was 47 +/- 6% and from residual or recurrent endocarditis was 78 +/- 5%. Predictors of hospital death were emergency surgery (p <0.003) and preoperative renal insufficiency (p <0.008). Predictors of late death were age > 70 years (p <0.002), renal failure (p <0.03) and fungal endocarditis (p <0.04). Conclusion: These findings demonstrate the increased perioperative, as well as postoperative, risks associated with PVE versus NVE. Cardiac and extracardiac manifestations of the disease, as well as fungal organisms, but not the activity of the endocarditis, were significant adverse determinants of late outcome.